| Trial ID: | L6163 |
| Source ID: | NCT05500937
|
| Associated Drug: |
Udca
|
| Title: |
Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: UDCA
|
| Outcome Measures: |
Primary: Changes of HbA1c, Changes of glycosylated hemoglobin after taking ursodeoxycholic acid for half a year, 12 months after enrollment | Secondary: Concentration of blood lipid, 12 months after enrollment|Concentration of fasting blood glucose, 12 months after enrollment|Concentration of fasting islets, 12 months after enrollment|Concentration of bile acids, 12 months after enrollment|Rate of MACE, 12 months after enrollment
|
| Sponsor/Collaborators: |
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
1000
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2021-03-01
|
| Completion Date: |
2024-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2022-09-28
|
| Locations: |
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China
|
| URL: |
https://clinicaltrials.gov/show/NCT05500937
|
